Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

BACKGROUND: Hospitalized acutely ill medical patients are at risk for fatal and major thromboembolic events. Whether use of extended-duration primary thromboprophylaxis can prevent such events is unknown. OBJECTIVES: The purpose of this study was to evaluate whether extended-duration rivaroxaban red...

Descripción completa

Detalles Bibliográficos
Autores principales: Spyropoulos, Alex C., Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory A., Steg, P. Gabriel, Weitz, Jeffrey I., Lu, Wentao, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308003/
https://www.ncbi.nlm.nih.gov/pubmed/32586587
http://dx.doi.org/10.1016/j.jacc.2020.04.071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308003/
https://www.ncbi.nlm.nih.gov/pubmed/32586587
http://dx.doi.org/10.1016/j.jacc.2020.04.071

Ejemplares similares